Filter Results :

Your search for Pharmaceuticals returned 5289 reports

Sort by


Australia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Drugmakers operating in Australia will face an increasingly challenging business environment as the Sixth Pharmacy Community Agreement's measures come into effect. This includes a 5% price cut to medicines listed on the F1 formulary for more than five years, as well as changes to the...

$ 1,295.00

Read More

Indonesia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Indonesian medical landscape will see a larger presence of private healthcare providers over medium term. Underpinning this expansion is the robust prospects for the industry, with the introduction of a Coordination of Benefits scheme allowing patients to supplement their coverag...

$ 1,295.00

Read More

Estonia Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Estonia's healthcare system is much more mature than its Central and Eastern European peers, but given the country's limited resources, the country is less appealing to pharmaceutical companies. Drugmakers can expect to see constrained revenue growth in the country as pricing pressur...

$ 1,295.00

Read More

Kuwait Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: With the recent oil strike representing a harbinger of significant political and economic turbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait's integration with neighbouring Gulf states and international partners. Headline Expenditure Proje...

$ 1,295.00

Read More

Kenya Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Many emerging market economies are increasingly exposed to the negative effect of sustained lower commodity prices. This is putting downward pressure on government finances and, as a consequence, healthcare budgets. We nevertheless maintain a positive long-term outlook for medicine d...

$ 1,295.00

Read More

France Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Despite the ongoing recovery in some high frequency indicators, subdued economic growth in France relative to regional peers will continue to weigh on the French government spending potential, posing downside risks to our pharmaceutical and healthcare sector forecasts. In line with o...

$ 1,295.00

Read More

Cameroon Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Although Cameroon's economic growth is expected to remain on track driven by public-private partnerships in strategic infrastructure projects, the country's pharmaceutical and healthcare sector will remain dependent on private out-of-pocket spending and global aid funds, which will w...

$ 1,295.00

Read More

Ecuador Pharmaceuticals and Healthcare Report

18 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Chinese investment in Ecuador's pharmaceutical and healthcare sector will continue to be pertinent for the country in order for it to meet the increasing demand of medicines within its public healthcare sector. Foreign generic drugmakers will, however, face significant competition fr...

$ 1,295.00

Read More

Squalene Market by Type (Animal-Sourced & Vegetable-Sourced) and End-Use Industry (Cosmetics, Pharmaceuticals & Food) - Global Forecasts to 2021

13 May 2016  |  Published by:  MarketsandMarkets
Squalene market to reach USD 211.7 billion by 2021 The global squalene market is estimated to reach a market size of USD 211.7 million by 2021 and is projected to register a CAGR of 10.2% between 2016 and 2021. Squalene has many beneficial properties such as anti-oxidation, anti-aging, stre...

$ 4,650.00

Read More

Denmark Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Although Denmark has a relatively small pharmaceutical market compared to its Western European counterparts, its high per capita spending makes it an attractive market for innovative drugmakers. An aging population and sizable non-communicable disease burden will drive high-value med...

$ 1,295.00

Read More

Argentina Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: In the near term, the substandard regulatory and market access environment will continue to tarnish Argentina's appeal to drugmakers. However, in the long term, Argentina stands among the most promising pharmaceutical markets in Latin America in terms of growth. In fact, rising deman...

$ 1,295.00

Read More

Kazakhstan Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The mid-term outlook for Kazakhstan's pharmaceutical and healthcare markets is mixed. The healthcare system is set to improve, with the introduction of a public health insurance system and e-health technology; however, the formation of the Eurasian Economic Union medicines market is ...

$ 1,295.00

Read More

Bahrain Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: Bahrain's pharmaceutical market will experience slight growth in 2016 as a result of medicine price cuts implemented in late 2015. The country's rising prevalence of lifestyle-related diseases and the uptake of compulsory health insurance will provide strong opportunities for multina...

$ 1,295.00

Read More

Czech Republic Pharmaceuticals and Healthcare Report

11 May 2016  |  Published by:  BMI Pharmaceuticals and Healthcare
BMI View: The Czech Republic will continue to be one of the most attractive markets in the CEE region for pharmaceutical and healthcare investment. A strong economic outlook will be the driving factor behind growth and with plans to further increase access to healthcare, pharmaceutical sales a...

$ 1,295.00

Read More

Homogenizers Market by Type (Ultrasonic, Pressure, Mechanical), by Valve Technology (Single-valve Assembly, Two-valve Assembly), by Application (Food & Dairy, Cosmetics, Pharmaceuticals, Chemical Processing, Biotechnology), by Geography - Forecast to 2021

10 May 2016  |  Published by:  MarketsandMarkets
Growing demand for novel food & beverage products to drive the market for homogenizers The global market for homogenizers is projected to grow from USD 1.53 billion in 2016 to reach USD 1.94 billion by 2021, at an estimated CAGR of 4.92% from 2016 to 2021. The homogenizers market is dri...

$ 4,650.00

Read More
Total 5289 records.